These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37254538)

  • 1. Polymorphic Variants of
    Bibi K; Fatima T; Sohrab S; Haider G; Zarina S; Ilyas A
    Protein Pept Lett; 2023; 30(7):587-596. PubMed ID: 37254538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy.
    McAlpine JA; Lu HT; Wu KC; Knowles SK; Thomson JA
    BMC Cancer; 2014 Aug; 14():621. PubMed ID: 25164070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2α/ATF4/CHOP axis in hepatocellular carcinoma.
    Kim S; Lee M; Song Y; Lee SY; Choi I; Park IS; Kim J; Kim JS; Kim KM; Seo HR
    J Exp Clin Cancer Res; 2021 Apr; 40(1):127. PubMed ID: 33838671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of VIPR1 suppresses hepatocellular carcinoma progression by regulating arginine and pyrimidine metabolism.
    Fu Y; Liu S; Rodrigues RM; Han Y; Guo C; Zhu Z; He Y; Mackowiak B; Feng D; Gao B; Zeng S; Shen H
    Int J Biol Sci; 2022; 18(11):4341-4356. PubMed ID: 35864952
    [No Abstract]   [Full Text] [Related]  

  • 5. Oncogenic Kaposi's Sarcoma-Associated Herpesvirus Upregulates Argininosuccinate Synthase 1, a Rate-Limiting Enzyme of the Citrulline-Nitric Oxide Cycle, To Activate the STAT3 Pathway and Promote Growth Transformation.
    Li T; Zhu Y; Cheng F; Lu C; Jung JU; Gao SJ
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRMT7 Interacts with ASS1 and Citrullinemia Mutations Disrupt the Interaction.
    Verma M; Charles RCM; Chakrapani B; Coumar MS; Govindaraju G; Rajavelu A; Chavali S; Dhayalan A
    J Mol Biol; 2017 Jul; 429(15):2278-2289. PubMed ID: 28587924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Argininosuccinate synthase 1 suppresses cancer cell invasion by inhibiting STAT3 pathway in hepatocellular carcinoma.
    Tao X; Zuo Q; Ruan H; Wang H; Jin H; Cheng Z; Lv Y; Qin W; Wang C
    Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):263-276. PubMed ID: 30883650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer.
    Delage B; Fennell DA; Nicholson L; McNeish I; Lemoine NR; Crook T; Szlosarek PW
    Int J Cancer; 2010 Jun; 126(12):2762-72. PubMed ID: 20104527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the Polyamine Synthesis Pathway Is Synthetically Lethal with Loss of Argininosuccinate Synthase 1.
    Locke M; Ghazaly E; Freitas MO; Mitsinga M; Lattanzio L; Lo Nigro C; Nagano A; Wang J; Chelala C; Szlosarek P; Martin SA
    Cell Rep; 2016 Aug; 16(6):1604-1613. PubMed ID: 27452468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer.
    Nicholson LJ; Smith PR; Hiller L; Szlosarek PW; Kimberley C; Sehouli J; Koensgen D; Mustea A; Schmid P; Crook T
    Int J Cancer; 2009 Sep; 125(6):1454-63. PubMed ID: 19533750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression.
    Kim SS; Xu S; Cui J; Poddar S; Le TM; Hayrapetyan H; Li L; Wu N; Moore AM; Zhou L; Yu AC; Dann AM; Elliott IA; Abt ER; Kim W; Dawson DW; Radu CG; Donahue TR
    Theranostics; 2020; 10(2):829-840. PubMed ID: 31903153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FXR/ASS1 axis attenuates the TAA-induced liver injury through arginine metabolism.
    Hong W; Peng X; Zhou X; Li P; Ye Z; Liang W
    Biochem Biophys Res Commun; 2022 Jun; 611():31-37. PubMed ID: 35477090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging.
    Allen MD; Luong P; Hudson C; Leyton J; Delage B; Ghazaly E; Cutts R; Yuan M; Syed N; Lo Nigro C; Lattanzio L; Chmielewska-Kassassir M; Tomlinson I; Roylance R; Whitaker HC; Warren AY; Neal D; Frezza C; Beltran L; Jones LJ; Chelala C; Wu BW; Bomalaski JS; Jackson RC; Lu YJ; Crook T; Lemoine NR; Mather S; Foster J; Sosabowski J; Avril N; Li CF; Szlosarek PW
    Cancer Res; 2014 Feb; 74(3):896-907. PubMed ID: 24285724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistance.
    Kim Y; Kobayashi E; Kubota D; Suehara Y; Mukaihara K; Akaike K; Ito A; Kaneko K; Chuman H; Kawai A; Kitano S
    Oncotarget; 2016 Oct; 7(43):70832-70844. PubMed ID: 27683125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles from human liver stem cells restore argininosuccinate synthase deficiency.
    Herrera Sanchez MB; Previdi S; Bruno S; Fonsato V; Deregibus MC; Kholia S; Petrillo S; Tolosano E; Critelli R; Spada M; Romagnoli R; Salizzoni M; Tetta C; Camussi G
    Stem Cell Res Ther; 2017 Jul; 8(1):176. PubMed ID: 28750687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argininosuccinate synthase 1 and periportal gene expression in sonic hedgehog hepatocellular adenomas.
    Nault JC; Couchy G; Caruso S; Meunier L; Caruana L; Letouzé E; Rebouissou S; Paradis V; Calderaro J; Zucman-Rossi J
    Hepatology; 2018 Sep; 68(3):964-976. PubMed ID: 29572896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argininosuccinate synthetase 1 (ASS1) is a common metabolic marker of chemosensitivity for targeted arginine- and glutamine-starvation therapy.
    Long Y; Tsai WB; Wang D; Hawke DH; Savaraj N; Feun LG; Hung MC; Chen HH; Kuo MT
    Cancer Lett; 2017 Mar; 388():54-63. PubMed ID: 27913198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming.
    Chen M; Zhang C; Liu W; Du X; Liu X; Xing B
    Mol Ther; 2022 Jun; 30(6):2354-2369. PubMed ID: 35192933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1.
    Qualls JE; Subramanian C; Rafi W; Smith AM; Balouzian L; DeFreitas AA; Shirey KA; Reutterer B; Kernbauer E; Stockinger S; Decker T; Miyairi I; Vogel SN; Salgame P; Rock CO; Murray PJ
    Cell Host Microbe; 2012 Sep; 12(3):313-23. PubMed ID: 22980328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM.
    Mörén L; Perryman R; Crook T; Langer JK; Oneill K; Syed N; Antti H
    BMC Cancer; 2018 Feb; 18(1):167. PubMed ID: 29422017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.